30
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy

, , &
Pages 189-198 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

T. D. Filippatos, E. Klouras, F. Barkas & M. Elisaf. (2016) Cholesteryl ester transfer protein inhibitors: challenges and perspectives. Expert Review of Cardiovascular Therapy 14:8, pages 953-962.
Read now

Articles from other publishers (10)

Irmak Sayın Alan & Bahadır Alan. 2018. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors.
Jorien Werumeus Buning, Lidya G. Dimova, Frank G. Perton, Uwe J. F. Tietge, André P. van Beek & Robin P. F. Dullaart. (2017) Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL. European Journal of Clinical Investigation 47:7, pages 494-503.
Crossref
Benjamin D. Weger, Meltem Weger, Benjamin Görling, Andrea Schink, Cédric Gobet, Céline Keime, Gernot Poschet, Bernard Jost, Nils Krone, Rüdiger Hell, Frédéric Gachon, Burkhard Luy & Thomas Dickmeis. (2016) Extensive Regulation of Diurnal Transcription and Metabolism by Glucocorticoids. PLOS Genetics 12:12, pages e1006512.
Crossref
I L Ross, N S Levitt, L Van der Merwe, D A Schatz, G Johannsson, C Dandara, T S Pillay & D J Blom. (2013) Investigation of glucocorticoid receptor polymorphisms in relation to metabolic parameters in Addison's disease. European Journal of Endocrinology 168:3, pages 403-412.
Crossref
R. P. F. Dullaart. (2009) Comment on high HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. European Journal of Clinical Investigation 39:6, pages 533-533.
Crossref
Patrick W.F. Hadoke, Javaid Iqbal & Brian R. Walker. (2009) Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. British Journal of Pharmacology 156:5, pages 689-712.
Crossref
Robin P. F. Dullaart, Jeroen L. Schols, Gerrit van der Steege, Peter M. J. Zelissen, Wim J. Sluiter & André P. van Beek. (2008) Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients . Clinical Endocrinology 69:3, pages 359-366.
Crossref
Robin P F DullaartWim J Sluiter. (2008) Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis . Pharmacogenomics 9:6, pages 747-763.
Crossref
Wilfried Le Goff, Maryse Guerin & M.John Chapman. (2004) Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacology & Therapeutics 101:1, pages 17-38.
Crossref
T. B. Twickler, M. J. M. Cramer, G. M. Dallinga-Thie, M. J. Chapman, D. W. Erkelens & H. P. F. Koppeschaar. (2003) Adult-Onset Growth Hormone Deficiency: Relation of Postprandial Dyslipidemia to Premature Atherosclerosis. The Journal of Clinical Endocrinology & Metabolism 88:6, pages 2479-2488.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.